Finally, FAP KO negatively regulated the CaMKIIδ-Calcineurin A-NFATc2 signaling pathway, thereby alleviating myocardial hypertrophy, fibrosis, inflammation, oxidative stress, apoptosis, and energy metabolism dysfunction in T2DM-induced HFpEF mice. Here, FAP is linked to type 2 diabetes mellitus.